ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels

Clinical Genetics

Volumn 61, Issue 2, 2002, Pages 115-125

  Zwarts, K Y ^a   Clee, S M ^a   Zwinderman, A H ^b   Engert, J C ^c   Singaraja, R ^a   Loubser, O ^a   James, E ^d   Roomp, K ^d   Hudson, T J ^c   Jukema, J W ^b   Kastelein, J J P ^e   Hayden, Michael R ^a  

^a Centre for Molecular Medicine and Therapeutics   (Canada)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MONTREAL GENERAL HOSPITAL   (Canada)

^d Xenon Genetics Inc   (Canada)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

ABCA1; Coronary artery disease; Lipids; Polymorphisms; Risk factors

Indexed keywords

ABC TRANSPORTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

5' UNTRANSLATED REGION; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; DISEASE SEVERITY; FAMILY HISTORY; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; INTRON; LIPID BLOOD LEVEL; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

5' UNTRANSLATED REGIONS; ATP-BINDING CASSETTE TRANSPORTERS; COHORT STUDIES; CORONARY ARTERIOSCLEROSIS; GENE EXPRESSION REGULATION; HUMANS; LIPIDS; MALE; MODELS, GENETIC; MUTATION; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RANDOM ALLOCATION; TIME FACTORS;

TRIXIS;

EID: 0036488074     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2002.610206.x     Document Type: Article

References (27)

1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997: 349: 1269-1276.
2. Corti M-C, Barbato G-M, Baggio G. Lipoprotein alterations and atherosclerosis in the elderly. Curr Opin Lipidol 1997: 8: 236-241.
3. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mänttäri M, Heinonen OP, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 1992: 85: 37-45.
4. Goldbourt U, Yaaris S, Medalie JH. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21 year follow-up of 8000 men. Arterioscler Thromb Vasc Biol 1997: 17: 107-113.
5. 2 cholesterol in normolipidemic men with coronary artery disease. Arterioscler Thromb Vasc Biol 1995: 15: 1043-1048.
6. Schaefer EJ, Lamon-Fava S, Ordovas JM, Cohn SD, Schaefer MM, Castelli WP, et al. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J Lipid Res 1994: 35: 871-882.
7. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995: 36: 211-228.
8. Hill SA, McQueen MJ. Reverse cholesterol transport - a review of the process and its clinical implications. Clin Biochem 1997: 30: 517-525.
9. Brooks-Wilson A, Marcil M, Clee SM, Zhang L, Roomp K, van Dam M, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999: 22: 336-345.
10. Marcil M, Brooks-Wilson A, Clee SM, Roomp K, Zhang L, Yu L, et al. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet 1999: 354: 1341-1346.
11. Bodzioch M, Orsó E, Klucken J, Langmann T, Böttcher A, Diederich W, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier Disease. Nat Genet 1999: 22: 347-351.
12. Rust S, Rosier M, Funke H, Amoura Z, Piette J-C, Deleuze J-F, et al. Tangier Disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999: 22: 352-355.
13. Fredrickson DS, Altrocchi PH, Avioli LV, Goodman DWS, Goodman HC. Tangier Disease. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med 1961: 55: 1016-1031.
14. Clee SM, Kastelein JJP, van Dam M, Marcil M, Roomp K, Zwarts KY, et al. HDL cholesterol levels and coronary artery disease in heterozygotes for ABCA1 mutations are predicted by cholesterol efflux levels and influenced by age. J Clin Invest 2000: 106: 1263-1270.
15. Brousseau ME, Eberhart GP, Dupuis J, Asztalos BF, Goldkamp AL, Schaefer EJ, et al. Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size. J Lipid Res 2000: 41: 1125-1135.
16. Clee SM, Zwinderman AH, Engert JC, Zwarts KY, Molhuizen HOF, Roomp K, et al. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 2001: 103: 1198-1205.
17. Ehrenborg E, Clee SM, Pimstone SN, Reymer PWA, Benlain P, Hoogendijk CF, et al. Ethnic variation and in vivo effects of the -93 t-g promoter variant in the lipoprotein lipase gene. Arterioscler Thromb Vasc Biol 1997: 17: 2672-2678.
18. Shen LX, Basilion JP, Stanton VP, Jnr. Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc Natl Acad Sci 1999: 96: 7871-7876.
19. Cavalli-Sforza LL. The DNA revolution in population genetics. Trends Genet 1998: 14: 60-65.
20. 2-adrenergic receptor regulate receptor expression. J Clin Invest 1998: 102: 1927-1932.
21. Maquat LE. The power of point mutations. Nat Genet 2001: 27: 5-6.
22. Pullinger CR, Hakamata H, Duchateau PN, Eng C, Aovizerat BE, Cho MH, et al. Analysis of hABC1 Gene 5′-End: additional peptide sequence, promoter region, and four polymorphisms. Biochem Biophys Res Commun 2000: 271: 451-455.
23. Jukema JW, Bruschke AUG, van Boven AJ, Reiber JHC, Bal ET, Zwinderman AH, et al. Effects of lipid lowering by pravastatin on the progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 1995: 91: 2528-2540.
24. Lee LG, Connell CR, Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nuc Ac Res 1993: 21: 3761-3766.
25. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′ -- >3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci 1991: 88: 7276-7280.
26. Lutucuta S, Ballantyne CM, Elghannam H, Gotto AM, Jr., Marian AJ. Novel polymorphisms in promoter region of ATP binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res 2001: 88: 969-973.
27. Singaraja RR, Bocher V, James ER, Clee SM, Zhang L, Leavitt BR, et al. Human ABCA1 BAC transgenic mice show increased HDL-C and apoAI dependant efflux stimulated by an internal promoter containing LXREs in intron 1. J Biol Chem 2001: 276: 33969-33979.